Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Agilon Health Inc has a consensus price target of $13.41 based on the ratings of 20 analysts. The high is $35 issued by Jefferies on October 20, 2021. The low is $4 issued by Deutsche Bank on August 9, 2024. The 3 most-recent analyst ratings were released by Deutsche Bank, Benchmark, and RBC Capital on August 9, 2024, August 8, 2024, and August 7, 2024, respectively. With an average price target of $7 between Deutsche Bank, Benchmark, and RBC Capital, there's an implied 82.29% upside for Agilon Health Inc from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Agilon Health (NYSE:AGL) was reported by Deutsche Bank on August 9, 2024. The analyst firm set a price target for $4.00 expecting AGL to rise to within 12 months (a possible 4.17% upside). 30 analyst firms have reported ratings in the last year.
The latest analyst rating for Agilon Health (NYSE:AGL) was provided by Deutsche Bank, and Agilon Health maintained their hold rating.
There is no last upgrade for Agilon Health
The last downgrade for Agilon Health Inc happened on February 26, 2024 when TD Cowen changed their price target from $12 to $6.5 for Agilon Health Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agilon Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agilon Health was filed on August 9, 2024 so you should expect the next rating to be made available sometime around August 9, 2025.
While ratings are subjective and will change, the latest Agilon Health (AGL) rating was a maintained with a price target of $5.00 to $4.00. The current price Agilon Health (AGL) is trading at is $3.84, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.